← All trials
NCT04297618
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2020
- Primary completion
- Nov 30, 2020
- Completion date
- Nov 30, 2020
- First posted
- Mar 5, 2020
- Last posted
- Apr 7, 2020
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of WaterlooLead sponsor
- University of WaterlooOverall official - principal investigator
- University of WaterlooOfficial
- NovartisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.